The determination of creatinine in serum based on the Jaffe reaction was evaluated with four current analysers. In particular, the comparability of results was determined also with survey specimens. Recalibration of 3 out of 4 modifications was necessary, based on the results of patient samples s verified with a HPLC-method. One of the methods proved to give an unacceptable scatter for the results in the lower r nge (30-150 μιηοΐ/ΐ).
Introduction
In a previous article we described the evaluation of four state-of-the-art methods for the measurement of creatinine in serum (1) . Two methods were based on the Jaffe reaction while the other two used an enzymatic approach. We conlcuded that both enzymatic procedures performed better, and that the two Jaffe methods differed in their accuracy.
Because of this study, and in view of earlier experience (2) we feit the need to check the accuracy of the creatinine determinations performed on four analysers currently used in o r laboratpry.
We restricted ourselves to the comparison of "around normal" samples (30-150 μιηοΐ/ΐ), the calibration of the Instruments and the most common interferents. We also assessed the methods by applying various quality control samples s used in the years 1992 and 1993 in the Dutch Quality Assessment Scheme (SKZL).
Materials and Methods

Instrumentation
The following Instruments were used and calibrated exactly according to the instructions of the various manufacturcrs: Serum samples were collected in various departments in the University Hospital Rotterdam. All samples were stored at -70 °C prior to use. We only used non-icteric, non-haemolytic and nonlipaemic specimens for the comparison studies. Samples were divided into two groups. Group I showed a uniform distribution of creatinine values between 40 and 150 μηιοΐ/ΐ (40 samples), and group II showed a uniform distribution of values 30 and 900 μηιοΐ/ΐ (17 samples).
Creatinine concentrations of all samples were verified with our HPLC reference method (3) . Remarks: 1. Correction was done with both SRM samples 2. The graph consisted of 17 data points in the r nge 30-900 μτηοΐ/ΐ 3. All coefficients of correlation were at least 0.99 nology (Gaithersburg, U. S. A.). The samples used for the recovery Statistical analyses study came from the Dutch Quality Assessment Foundation (SKZL). They were used in the quality control schemes in 1992 Regression an lysis was performed according to Passing & and 1993 . Seven were of human origin and seven of animal origin. Bablok (4).
Interference study A restricted interference study was done with spiked albumin solutions s described earlier (2) . We only studied the influenee of Actual Situation haemoglobin, lipids (Intralipid®) and acetone (0-13.6 mmol/1). Using the regression lines calculated from the data in table l, all the results of groups I and II were recalculated. Table 2 shows only the group II data, which represent a comparison between the actual (= manufacturer set) and the real (= SRM based) calibration graph. Recalculation of all group I results gave an improvement in accuracy.
Interference study
The results of interference by haemoglobin, lipids and acetone in albumin solution (creatinine concentration 100 μπιοΐ/ΐ) are given in table 3 while the measurements of the icteric serum samples are tabulated in table 4.
Recovery
All recovery experiments with quality control samples are described in table 5. We only used specimens with HPLC-values between 30 and 150 μπ\ο1/1.
Discussion
Since creatinine is important in clinical medicine, it is frustrating that the overall accuracy is still inadequate, despite all the modifications and improvements. It follows from all our evaluation work that we produce erroneous creatinine results every day. The number of errors is not known, but fortunately we feel that most of them will not effect patient care. However, we cannot accept the analytical errors found in our study, despite its limited design. In this respect, our study confirms the results of the study reported by Vassault et al. (5), although this was designed difFerently. As a multicentre survey, it described the actual Situation in France with regard to creatinine determination, with the aim of pro* posing a selected method. No firm conclusion could be drawn, except a negative one regarding the imprecision and inaccuracy. It is clear from figure l in our study that three methods were calibrated wrongly (Hitachi 911, ELAN and Dimension) while one (ELAN) also showed a large scatter. Table l shows the improvements after recalibration with both SRM samples. We wondered whether the results obtained after recalibration could meet objective accuracy criteria. Applying 4.4% (6) s a maximal allowable deviation in 95% of the experiments, we found that 58% of the resulfs^for group I samples in the Chem-1 to be acceptable, for the Hitachi 55%, for the ELAN 23%, and for the Dimension 75%. It is stressed again that all samples were taken at random from our routine production, and they showed no visible peculiarities.
Most of the deviating results were found in the lower r nge (< 60 μτηοΐ/ΐ) which makes all methods questionable for paediatric work.
The question arises s to what more we can expect from creatinine methods based on the Jaffe reaction. This topic has been intensively studibd by several groups (7-13), unfortunately without firm conclusions, taking into account all the interfefence problems that may be encountered with clinical specimens. A limited ex inple of variability due t interference is shown in tables 3 and 4.
We therefore have to accept that there is at the moment no Jaffe modification that is completely satisfactory. There is much liter ture to confirm this (14, 15) .
One solution may be the application of more specific enzymatic methods. Without doubt this would mean an improvement in accuracy, s we have also shown (1). Many laboratories changed over in the last five years from Jaffe reaction-based methods to one of the enzymatic procedures. In the Netherlands only 4% of laboratories used enzymatic methods in 1989; in 1994 this is 14% (the majority of methods being so-called dry-chemistry). German surveys show ne rly 10% in 1989 and about 35% now. Unfortunately, enzymatic creatinine methods are also prone to interference (l, 16) though less IhanJqffemethods. As suggested by Bacon et al. a possible solution is a combination of an enzymatic and a kinetic approach (17) .
A second drawback that needs to be overcome is the high cost of enzymatic creatinine reagents.
Finally, we wish to discuss the external assessment of creatinine methods. It is clear from table 5 that only well-documented samples can be used in surveys. When the presentation of the data is redesigned and the extreme outliers are omitted (samples 4, 7 and 9) the picture presented in figure 2 still confirms this observation.
We are aware that the number of samples we used was limited. Nevertheless, it raises the question of the value of surveying the Jaffe reaction-based creatinine determination with varying control samples.
In this respect it is also worthwhile to mention the work ofKenny (18) who analysed various creatinine methods, predominantly based on the Jaffe reaction. In his effort to explain the large Variation seen in surveys performed with samples spiked with interfering substances, he detected various reaction patterns.
Finally, the determination of creatinine deserves critical and constructive attention from the clinical chemical Professional. However, this also holds for manufacturers. Manufacturers should be obliged to provide sufficient analytical and clinical evaluation Information, at least for the most important laboratory quantities. Sometimes they do. It is, unfortunately, not common practice.
